In contrast, glioma pathogenesis-related protein 1 (GLIPR1) is down-regulated in prostate cancer, while forced GLIPR1 overexpression is pro-apoptotic in prostate cancer cells and is suggested as a prostate-cancer therapy [211]. The gene discussed is GLIPR1; the disease is prostate cancer.